First Light Asset Management, LLC Glaukos Corp Transaction History

First Light Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $19.4 Million - $34.5 Million	-409,144 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$73.06 - $97.7 $9.02 Million - $12.1 Million	-123,513 Reduced 23.19%	409,144 $34.7 Million
Q1 2021 May 17, 2021	SELL	$70.43 - $97.42 $10.3 Million - $14.2 Million	-145,650 Reduced 21.47%	532,657 $44.7 Million
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $1.37 Million - $2.11 Million	28,018 Added 4.31%	678,307 $51 Million
Q3 2020 Nov 13, 2020	SELL	$37.23 - $50.97 $27,252 - $37,310	-732 Reduced 0.11%	650,289 $32.2 Million
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $16.1 Million - $26.2 Million	560,456 Added 618.84%	651,021 $25 Million
Q1 2020 May 15, 2020	BUY	$25.53 - $70.14 $2.31 Million - $6.35 Million	90,565 New	90,565 $2.8 Million

303

47M

75.3K

157K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.11B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.